![]() |
Home
Geschichte
|
HIV
Medicine
Wer ?
Was ?
FMI
|
Flying
Publisher
|
|
HIV.NET 2007 Nachrichten HAART Klinik Medikamente Kongressberichte Mailing-Liste
|
Nachrichten zur Übersicht
Cagliari, 02.01.07 - Marcus Altfeld, Autor des HIV.NET-Kapitels über die akute HIV-Infektion, hat
uns unterrichtet, daß
an der Oxford University Postdoc-Stellen für "HIV T cell immunology" ausgeschrieben sind. Hier die
vollständige Nachricht:
We are looking for a motivated post-doc (or post-docs) (MD or PhD) who has
completed her/his research thesis (Dr. med. or Dr. rer. nat). Candidates with solid experimental
laboratory research experience that has resulted into previous publication in international
peer-reviewed journals are encouraged to apply. A minimal commitment of 2 years is expected, and
assistance with fellowship applications to DFG or DAAD will be provided. We have openings for research scientists to work in our group at the Peter
Medawar Building for Pathogen research, University of Oxford. The overarching aim of the work
undertaken in the applicant?s research group is to better understand what are the CD8+ T cell
responses mediating effective control of adult and paediatric HIV infection. In a population-based study in KwaZulu-Natal, South Africa, we recently showed
that only Gag-specific CD8+ T cell responses are associated with low viraemia in chronic infection.
Env- or Accessory/Regulatory-specific responses are associated with high viral loads1.
The first aim of the proposed work is therefore to determine whether Gag-specific responses are
inherently more effective than non-Gag-specific responses, or whether these discordant associations
with viral load are merely the consequence of chronic infection. The second aim is to determine whether HIV adaptation at an individual level is
reflected by adaptation at a population level to these effective CD8+ T cell responses in Gag.
Preliminary studies we have undertaken prompt the hypothesis that effective responses may persist at
the population level even, as though virus adapts within individual subjects, because of fitness
costs resulting from particular escape mutations2-4. However, it is also clear that the
virus can adapt to costly escape variants via the selection of compensatory mutations. We will be
studying C-clade infected cohorts of HIV-infected persons in subSaharan Africa (including South
Africa, Zambia, Botswana) and B-clade infected cohorts in UK and in the Caribbean. The third aim is to extend studies initiated to examine whether CD8+ T cell
response play an important role in control of paediatric HIV infection5. Our preliminary
data suggest that they do, both via the specificity of the responses generated in infancy by the
child6, and also via the impact maternal CD8+ T cell responses might have on both the
specificity of the responses in the child7 and on the replicative capacity of transmitted
virus. References: 1. Kiepiela, P. et al. CD8+ T cell responses to different HIV
proteins have discordant associations with viral load. Nature Medicine, 2007, in
press 2. Leslie, AJ, et al, Transmission and accumulation of CTL escape
variants drive negative associations between HIV polymorphisms and HLA. Nature Medicine.
2004 3. Leslie, AJ, et al, Journal of Experimental Medicine, 2005 4. Martinez-Picado, J, Fitness cost of escape mutations in p24 Gag in association
with control of human immunodeficiency virus type 1. Journal of Virology, 2006 5. Prendergast A, et al, Paediatric HIV infection:
global perspectives, progress and future challenges. Lancet, 2007, in
press 6. Feeney, ME, et al, Immune escape precedes breakthrough HIV-1
viremia and broadening of the CTL response in a HLA-B27-positive long-term nonprogressing child,
Journal of Virology, 2004 7. Goulder PJR, et al, Evolution and transmission of stable CTL escape
mutants in HIV infection. Nature, 2001 Additional selected publications from our group:
Contact information: Professor Philip Goulder, Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford OX1 3SY Tel: +44-1865-281884 Fax: +44-1865-281236 Email: philip.goulder@ndm.ox.ac.uk
|
|
Wichtiger Hinweis für die Leser
|
||||